Open AccessVortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetes
Author(s) -
Carlos Alfonso TovillaZárate,
Antonia Pérez-Mandujano,
Iris Rubí Ramírez-González,
Ana Fresán,
Samuel Suárez-Méndez,
Esteban Martínez-Villaseñor,
Ester Rodríguez-Sánchez,
Mario Villar-Soto,
María Lilia LópezNarváez,
Thelma Beatriz GonzálezCastro,
Jorge L. Blé-Castillo,
Isela Esther JuárezRojop
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.10.56
Subject(s) - vortioxetine , sertraline , depression (economics) , type 2 diabetes , medicine , antidepressant , body mass index , diabetes mellitus , psychiatry , endocrinology , hippocampus , economics , macroeconomics